Literature DB >> 24292823

Arrestin interactions with G protein-coupled receptors.

Martin J Lohse1, Carsten Hoffmann.   

Abstract

G-protein-coupled receptors (GPCRs) are the primary interaction partners for arrestins. The visual arrestins, arrestin1 and arrestin4, physiologically bind to only very few receptors, i.e., rhodopsin and the color opsins, respectively. In contrast, the ubiquitously expressed nonvisual variants β-arrestin1 and 2 bind to a large number of receptors in a fairly nonspecific manner. This binding requires two triggers, agonist activation and receptor phosphorylation by a G-protein-coupled receptor kinase (GRK). These two triggers are mediated by two different regions of the arrestins, the "phosphorylation sensor" in the core of the protein and a less well-defined "activation sensor." Binding appears to occur mostly in a 1:1 stoichiometry, involving the N-terminal domain of GPCRs, but in addition a second GPCR may loosely bind to the C-terminal domain when active receptors are abundant.Arrestin binding initially uncouples GPCRs from their G-proteins. It stabilizes receptors in an active conformation and also induces a conformational change in the arrestins that involves a rotation of the two domains relative to each other plus changes in the polar core. This conformational change appears to permit the interaction with further downstream proteins. The latter interaction, demonstrated mostly for β-arrestins, triggers receptor internalization as well as a number of nonclassical signaling pathways.Open questions concern the exact stoichiometry of the interaction, possible specificity with regard to the type of agonist and of GRK involved, selective regulation of downstream signaling (=biased signaling), and the options to use these mechanisms as therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24292823     DOI: 10.1007/978-3-642-41199-1_2

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  21 in total

Review 1.  The ins and outs of adrenergic signaling.

Authors:  Martin J Lohse
Journal:  J Mol Med (Berl)       Date:  2015-07-23       Impact factor: 4.599

2.  Identification of Phosphorylation Codes for Arrestin Recruitment by G Protein-Coupled Receptors.

Authors:  X Edward Zhou; Yuanzheng He; Parker W de Waal; Xiang Gao; Yanyong Kang; Ned Van Eps; Yanting Yin; Kuntal Pal; Devrishi Goswami; Thomas A White; Anton Barty; Naomi R Latorraca; Henry N Chapman; Wayne L Hubbell; Ron O Dror; Raymond C Stevens; Vadim Cherezov; Vsevolod V Gurevich; Patrick R Griffin; Oliver P Ernst; Karsten Melcher; H Eric Xu
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

3.  Downregulation of a GPCR by β-Arrestin2-Mediated Switch from an Endosomal to a TGN Recycling Pathway.

Authors:  Nazish Abdullah; Muheeb Beg; David Soares; Jeremy S Dittman; Timothy E McGraw
Journal:  Cell Rep       Date:  2016-12-13       Impact factor: 9.423

4.  Muscarinic receptor regulates extracellular signal regulated kinase by two modes of arrestin binding.

Authors:  Seung-Ryoung Jung; Christopher Kushmerick; Jong Bae Seo; Duk-Su Koh; Bertil Hille
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-26       Impact factor: 11.205

5.  The amyloid precursor protein modulates α2A-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment.

Authors:  Fang Zhang; Mary Gannon; Yunjia Chen; Lufang Zhou; Kai Jiao; Qin Wang
Journal:  FASEB J       Date:  2017-06-23       Impact factor: 5.191

Review 6.  The emerging roles of β-arrestins in fibrotic diseases.

Authors:  Yuan-jing Gu; Wu-yi Sun; Sen Zhang; Jing-jing Wu; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2015-09-21       Impact factor: 6.150

7.  How GPCR Phosphorylation Patterns Orchestrate Arrestin-Mediated Signaling.

Authors:  Naomi R Latorraca; Matthieu Masureel; Scott A Hollingsworth; Franziska M Heydenreich; Carl-Mikael Suomivuori; Connor Brinton; Raphael J L Townshend; Michel Bouvier; Brian K Kobilka; Ron O Dror
Journal:  Cell       Date:  2020-12-08       Impact factor: 41.582

8.  Scaffolding mechanism of arrestin-2 in the cRaf/MEK1/ERK signaling cascade.

Authors:  Changxiu Qu; Ji Young Park; Min Woo Yun; Qing-Tao He; Fan Yang; Kiae Kim; Donghee Ham; Rui-Rui Li; T M Iverson; Vsevolod V Gurevich; Jin-Peng Sun; Ka Young Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

9.  Visualization of arrestin recruitment by a G-protein-coupled receptor.

Authors:  Arun K Shukla; Gerwin H Westfield; Kunhong Xiao; Rosana I Reis; Li-Yin Huang; Prachi Tripathi-Shukla; Jiang Qian; Sheng Li; Adi Blanc; Austin N Oleskie; Anne M Dosey; Min Su; Cui-Rong Liang; Ling-Ling Gu; Jin-Ming Shan; Xin Chen; Rachel Hanna; Minjung Choi; Xiao Jie Yao; Bjoern U Klink; Alem W Kahsai; Sachdev S Sidhu; Shohei Koide; Pawel A Penczek; Anthony A Kossiakoff; Virgil L Woods; Brian K Kobilka; Georgios Skiniotis; Robert J Lefkowitz
Journal:  Nature       Date:  2014-06-22       Impact factor: 49.962

10.  β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle.

Authors:  Susanne Nuber; Ulrike Zabel; Kristina Lorenz; Andreas Nuber; Graeme Milligan; Andrew B Tobin; Martin J Lohse; Carsten Hoffmann
Journal:  Nature       Date:  2016-03-23       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.